Primary and secondary prevention of stroke and systemic embolism with rivaroxaban in patients with non-valvular atrial fibrillation: Sub-analysis of the EXPAND Study

The EXPAND Study examined the real-world efficacy and safety of rivaroxaban for the prevention of stroke and systemic embolism (SE) in Japanese patients with non-valvular atrial fibrillation (NVAF). In this sub-analysis, we compared the differences in efficacy and safety between patients with and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchiyama, Shinichiro, Atarashi, Hirotsugu, Inoue, Hiroshi, Kitazono, Takanari, Yamashita, Takeshi, Shimizu, Wataru, Ikeda, Takanori, Kamouchi, Masahiro, Kaikita, Koichi, Fukuda, Koji, Origasa, Hideki, Shimokawa, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347661/
https://www.ncbi.nlm.nih.gov/pubmed/29980835
http://dx.doi.org/10.1007/s00380-018-1219-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347661/
https://www.ncbi.nlm.nih.gov/pubmed/29980835
http://dx.doi.org/10.1007/s00380-018-1219-0

Ejemplares similares